Literature DB >> 19332387

Risk factors for endometrial cancer in Turkish women: results from a hospital-based case-control study.

Nesrin Reis1, Nezihe Kizilkaya Beji.   

Abstract

PURPOSE OF THE RESEARCH: The aim of this study was to investigate the association between risk factors and endometrial cancer in Turkish women. METHODS AND SAMPLE: In a hospital-based case-control study conducted in Istanbul, 285 patients with histologically confirmed endometrial cancer were compared with 1050 controls, admitted to the different departments of the same hospital. Odds ratios (OR) and 95% confidence intervals (CI) were obtained from multivariate logistic regression analysis, fitted by the method of maximum likelihood. KEY
RESULTS: Risk factors for endometrial cancer were found to be the state of lower education (OR=2.53, 5% CI: 1.41-4.54), history of hypertension or diabetes (OR=3.26, 95% CI: 2.21-4.80), (OR=3.56, 95% CI: 2.02-6.27), lower parity (OR=3.89, 95% CI: 2.60-5.82), early menarche age (OR=9.43, 95% CI: 5.35-16.62) and HRT use (OR=2.66, 5% CI: 1.40-5.06).
CONCLUSIONS: In conclusion, our results are supportive of the hypothesis that having a history of chronic disease, lower parity, early menarche and use of HRT were increased-risk factors but negative family history of cancer was decreased-risk factor for endometrial cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19332387     DOI: 10.1016/j.ejon.2009.01.007

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  9 in total

1.  Association of gene polymorphisms in ABO blood group chromosomal regions and menstrual disorders.

Authors:  Yong Su; Gui-Lian Kong; Ya-Li Su; Yan Zhou; Li-Fang Lv; Qiong Wang; Bao-Ping Huang; Rui-Zhi Zheng; Quan-Zhong Li; Hui-Juan Yuan; Zhi-Gang Zhao
Journal:  Exp Ther Med       Date:  2015-04-08       Impact factor: 2.447

2.  Histopathological pattern of endometrial biopsies in patients with abnormal uterine bleeding in a tertiary referral hospital in Jordan.

Authors:  Eman Husssein Alshdaifat; Sami Saif El-Deen Al-Horani; Majd Mahmoud Al-Sous; Sharaf Al-Horani; Fernas Emile Sahawneh; Amer Mahmoud Sindiani
Journal:  Ann Saudi Med       Date:  2022-06-02       Impact factor: 1.707

Review 3.  Metabolic syndrome and endometrial cancer: a meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Dario Giugliano
Journal:  Endocrine       Date:  2013-05-03       Impact factor: 3.633

4.  Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes.

Authors:  Muhammed Al-Jarrah; Ismail Matalka; Hasan Al Aseri; Alia Mohtaseb; Irina V Smirnova; Lesya Novikova; Lisa Stehno-Bittel; Ahed Alkhateeb
Journal:  J Clin Med Res       Date:  2010-10-11

5.  Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies.

Authors:  Dagfinn Aune; Abhijit Sen; Lars J Vatten
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

6.  Global, Regional, and National Burden of Endometrial Cancer, 1990-2017: Results From the Global Burden of Disease Study, 2017.

Authors:  Shuang Zhang; Ting-Ting Gong; Fang-Hua Liu; Yu-Ting Jiang; Hui Sun; Xiao-Xin Ma; Yu-Hong Zhao; Qi-Jun Wu
Journal:  Front Oncol       Date:  2019-12-19       Impact factor: 6.244

7.  Spatiotemporal trends in burden of uterine cancer and its attribution to body mass index in 204 countries and territories from 1990 to 2019.

Authors:  Songbo Li; Hui Chen; Tongchao Zhang; Rongrong Li; Xiaolin Yin; Jinyu Man; Qiufeng He; Xiaorong Yang; Ming Lu
Journal:  Cancer Med       Date:  2022-02-13       Impact factor: 4.711

Review 8.  Breastfeeding and the incidence of endometrial cancer: A meta-analysis.

Authors:  Baojian Zhan; Xiaoqin Liu; Fang Li; Dongfeng Zhang
Journal:  Oncotarget       Date:  2015-11-10

9.  Changes in Uterine Cancer Incidence Rates in Egypt.

Authors:  Saad Alshahrani; Amr S Soliman; Ahmed Hablas; Mohamed Ramadan; Jane L Meza; Steven Remmenga; Ibrahim A Seifeldein; Robert M Chamberlain
Journal:  Obstet Gynecol Int       Date:  2018-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.